COMPANY PROFILE // THE 014 REPORT
KORU Medical Systems, Inc.
KRMD (Nasdaq) · Formerly: REPRO MED SYSTEMS INC
Assembled from 2 government sources in 2.3 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.
KORU Medical Systems, Inc. is an SEC-registered operating company in surgical & medical instruments & apparatus, incorporated in DE, based in Mahwah, NJ; listed as KRMD (Nasdaq).[source] It reported revenue of $41.1 million for the fiscal year ended 2025-12-31.[source] It has filed 79 documents with the SEC in the last 12 months; the latest is Form 4, filed 2026-11-20.[source] Its largest institutional holders on 13F filings are First Light Asset Management, LLC, Topline Capital Management, LLC, BlackRock, Inc. (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- First Light Asset Management, LLC$14.2M
- Topline Capital Management, LLC$14.2M
- BlackRock, Inc.$11.0M
- VANGUARD CAPITAL MANAGEMENT LLC$7.6M
- GEODE CAPITAL MANAGEMENT, LLC$4.7M
- Simcoe Capital LLC$3.5M
- Meros Investment Management, LP$3.2M
- Lionhunter Capital Management, LLC$2.9M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Adams Thomas Edward · Chief Financial Officer (Officer) · latest Form 4 2026-03-18 · filing · LinkedIn search
- KALBERMATTEN ADAM R · President-Chief Commercial Off (Officer) · latest Form 4 2026-03-18 · filing · LinkedIn search
- Pazdan Christopher · Chief Operating Officer (Officer) · latest Form 4 2026-03-18 · filing · LinkedIn search
- Schiller Eric · Chief Technology Officer (Officer) · latest Form 4 2026-01-15 · filing · LinkedIn search
- Tharby Linda M · Chief Executive Officer (Director,Officer) · latest Form 4 2026-03-18 · filing · LinkedIn search
- CASCELLA ROBERT · Director · latest Form 4 2026-01-02 · filing · LinkedIn search
- FLETCHER R JOHN · Director,Other · latest Form 4 2026-01-02 · filing · LinkedIn search
- French Donna · Director · latest Form 4 2026-01-02 · filing · LinkedIn search
- Manko Joseph M. Jr. · Director,10% owner · latest Form 4 2026-02-13 · filing · LinkedIn search
- Matin Shahriar · Director · latest Form 4 2026-01-02 · filing · LinkedIn search
- WHOLIHAN EDWARD · Director · latest Form 4 2026-01-02 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- Royer Cooper Cohen Braunfeld LLC · Exhibit 5.1 legal opinion, S-3 filed 2026-11-16
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0000704440 | source |
| EIN | 13-3044880 | source |
| Business address (SEC) | 100 CORPORATE DRIVE, MAHWAH, NJ, 07430 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 129 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 174 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 3841 (surgical & medical instruments & apparatus): 149 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- STRYKER CORP · 101 SEC filings in 12 months · 1 flag · $502.2M federal (possible match)
- ORASURE TECHNOLOGIES INC · 69 SEC filings in 12 months · 2 flags · $480.7M federal (possible match)
- 3M CO · 124 SEC filings in 12 months · $465.5M federal (possible match)
- BOSTON SCIENTIFIC CORP · 110 SEC filings in 12 months · 1 flag · $140.1M federal (possible match)
- CERUS CORP · 71 SEC filings in 12 months · 2 flags · $126.6M federal (possible match)
- BAXTER INTERNATIONAL INC · 84 SEC filings in 12 months · 1 flag · $54.7M federal (possible match)
- Inspire Medical Systems, Inc. · 100 SEC filings in 12 months · 4 flags · $22.3M federal (possible match)
- ACCURAY INC · 103 SEC filings in 12 months · 4 flags · $13.9M federal (possible match)
- NeuroPace Inc · 61 SEC filings in 12 months · $10.3M federal (possible match)
- TELEFLEX INC · 64 SEC filings in 12 months · 1 flag · $9.4M federal (possible match)
- Cytosorbents Corp · 30 SEC filings in 12 months · 4 flags · $5.0M federal (possible match)
- IRADIMED CORP · 70 SEC filings in 12 months · 1 flag · $4.0M federal (possible match)
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- CELESTICA INC · CASCELLA ROBERT
- ClearPoint Neuro, Inc. · FLETCHER R JOHN
- MYOMO, INC. · Manko Joseph M. Jr.
- Mirion Technologies, Inc. · CASCELLA ROBERT
- Neuronetics, Inc. · CASCELLA ROBERT
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-16 filing S-3 · SEC EDGAR
- 2026-11-12 filing S-8 · SEC EDGAR
- 2026-11-10 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-10 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-08-14 filing 8-K items 5.03,9.01 · SEC EDGAR
- 2026-08-05 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-05 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-08-03 filing 144 · SEC EDGAR
- 2026-06-30 filing 8-K items 1.01,9.01 · SEC EDGAR
- 2026-05-21 filing 8-K items 5.07 · SEC EDGAR
- 2026-05-14 filing 144 · SEC EDGAR
- 2026-05-06 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-06 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-09 filing Proxy statement · SEC EDGAR
- 2026-04-03 filing 8-K items 1.01,2.03,9.01 · SEC EDGAR
- 2026-03-16 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-03-12 filing Annual report (10-K) · SEC EDGAR
- 2026-03-12 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-02-13 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-02-11 filing 8-K items 5.03,9.01 · SEC EDGAR
- 2026-01-15 insider First Form 3/4/5 on record for Schiller Eric (Chief Technology Officer) · SEC Forms 3/4/5
- 2026-01-12 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-01-05 filing S-8 · SEC EDGAR
- 2025-11-25 filing 8-K items 1.01,9.01 · SEC EDGAR
- 2025-11-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-11-12 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-08-13 filing S-8 · SEC EDGAR
- 2025-08-11 insider First Form 3/4/5 on record for Adams Thomas Edward (Chief Financial Officer) · SEC Forms 3/4/5
- 2025-08-11 insider First Form 3/4/5 on record for KALBERMATTEN ADAM R (President-Chief Commercial Off) · SEC Forms 3/4/5
- 2025-08-11 insider First Form 3/4/5 on record for Pazdan Christopher (Chief Operating Officer) · SEC Forms 3/4/5
105 earlier entries
- 2025-08-06 filing Quarterly report (10-Q)
- 2025-08-06 filing 8-K items 2.02,9.01
- 2025-05-15 filing 8-K items 5.07
- 2025-05-07 filing Quarterly report (10-Q)
- 2025-05-07 filing 8-K items 2.02,9.01
- 2025-04-23 insider First Form 3/4/5 on record for Tharby Linda M (Chief Executive Officer)
- 2025-04-21 filing 144
- 2025-04-07 officer change 8-K items 5.02,7.01
- 2025-04-04 filing 8-K items 1.01,9.01
- 2025-04-04 filing Proxy statement
- 2025-04-02 insider First Form 3/4/5 on record for CASCELLA ROBERT (Director)
- 2025-04-02 insider First Form 3/4/5 on record for FLETCHER R JOHN (Director,Other)
- 2025-04-02 insider First Form 3/4/5 on record for French Donna (Director)
- 2025-04-02 insider First Form 3/4/5 on record for Manko Joseph M. Jr. (Director,10% owner)
- 2025-04-02 insider First Form 3/4/5 on record for Matin Shahriar (Director)
- 2025-04-02 insider First Form 3/4/5 on record for WHOLIHAN EDWARD (Director)
- 2025-03-19 filing 144
- 2025-03-19 filing 144
- 2025-03-17 filing 144
- 2025-03-12 filing S-8 POS
- 2025-03-12 filing S-8
- 2025-03-12 filing Annual report (10-K)
- 2025-03-12 filing 8-K items 2.02,9.01
- 2025-01-21 filing SCHEDULE 13D/A
- 2025-01-13 filing 8-K items 2.02,7.01,9.01
- 2024-11-13 filing Quarterly report (10-Q)
- 2024-11-13 filing 8-K items 2.02,9.01
- 2024-08-21 officer change 8-K items 5.02,9.01
- 2024-08-07 filing 8-K items 2.02,9.01
- 2024-08-07 filing Quarterly report (10-Q)
- 2024-07-24 officer change 8-K items 1.01,5.02,9.01
- 2024-07-10 filing S-8
- 2024-07-10 filing S-8 POS
- 2024-06-03 filing 8-K items 4.01,9.01
- 2024-05-14 filing 8-K items 5.07
- 2024-05-01 filing Quarterly report (10-Q)
- 2024-05-01 filing 8-K items 2.02,9.01
- 2024-04-11 filing 8-K items 8.01,9.01
- 2024-03-28 filing Proxy statement
- 2024-03-18 filing PRE 14A
- 2024-03-13 filing 8-K items 1.01,2.02,2.03,3.02,9.01
- 2024-03-13 filing Annual report (10-K)
- 2024-01-02 filing SC 13D/A
- 2023-11-08 filing Quarterly report (10-Q)
- 2023-11-08 officer change 8-K items 2.02,5.02,8.01,9.01
- 2023-10-04 officer change 8-K items 5.02,8.01,9.01
- 2023-08-09 filing Quarterly report (10-Q)
- 2023-08-09 filing 8-K items 2.02,9.01
- 2023-08-02 officer change 8-K items 2.02,5.02,9.01
- 2023-07-18 filing S-8
- 2023-06-27 officer change 8-K items 5.02,8.01,9.01
- 2023-05-31 filing EFFECT
- 2023-05-26 filing CORRESP
- 2023-05-26 filing S-3/A
- 2023-05-22 filing UPLOAD
- 2023-05-18 filing S-3
- 2023-05-18 filing S-8 POS
- 2023-05-18 filing S-8 POS
- 2023-05-17 filing 8-A12B/A
- 2023-05-17 officer change 8-K items 1.01,3.03,5.02,5.03,5.07,8.01,9.01
- 2023-05-04 filing Quarterly report (10-Q)
- 2023-05-04 filing 8-K items 2.02,9.01
- 2023-04-18 filing 3/A
- 2023-03-29 filing Proxy statement
- 2023-03-08 filing Annual report (10-K)
- 2023-03-08 filing 8-K items 2.02,9.01
- 2023-02-24 filing SC 13D/A
- 2022-11-09 filing Quarterly report (10-Q)
- 2022-11-09 filing 8-K items 2.02,9.01
- 2022-08-03 filing Quarterly report (10-Q)
- 2022-08-03 filing 8-K items 2.02,9.01
- 2022-07-06 filing 8-K items 1.01,2.03,9.01
- 2022-06-30 filing S-8
- 2022-06-28 filing 8-K items 5.03,9.01
- 2022-06-03 name change Name changed from REPRO MED SYSTEMS INC
- 2022-05-18 officer change 8-K items 1.01,5.02,9.01
- 2022-05-10 filing 8-K items 5.07
- 2022-05-04 filing Quarterly report (10-Q)
- 2022-05-04 filing 8-K items 2.02,9.01
- 2022-03-18 filing Proxy statement
- 2022-03-07 filing PRE 14A
- 2022-03-02 filing Annual report (10-K)
- 2022-03-02 filing 8-K items 2.02,9.01
- 2022-01-07 filing S-8
- 2021-12-10 filing 8-K items 7.01
- 2021-12-07 filing 8-K items 7.01,9.01
- 2021-11-10 filing Quarterly report (10-Q)
- 2021-11-10 filing 8-K items 2.02,9.01
- 2021-08-11 filing 8-K items 2.02,9.01
- 2021-08-11 filing Quarterly report (10-Q)
- 2021-05-19 filing 8-K items 5.07
- 2021-05-12 filing Quarterly report (10-Q)
- 2021-05-12 filing 8-K items 2.02,9.01
- 2021-04-06 filing SC 13D/A
- 2021-04-05 filing Proxy statement
- 2021-03-23 filing PRE 14A
- 2021-03-23 filing 8-K items 2.02,9.01
- 2021-03-23 filing Annual report (10-K)
- 2021-03-19 officer change 8-K items 5.02,8.01,9.01
- 2021-02-11 officer change 8-K items 5.02,9.01
- 2021-01-26 officer change 8-K items 2.02,5.02,9.01
- 2020-11-17 filing 8-K items 7.01,9.01
- 2020-11-17 filing 8-K items 8.01,9.01
- 2020-11-12 filing Quarterly report (10-Q)
- 2020-11-04 filing 8-K items 2.02,9.01
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-16 (within 7 days) S-3 filed (FORM S-3 REGISTRATION STATEMENT)
- 2026-11-12 (within 30 days) S-8 filed (FORM S-8 REGISTRATION STATEMENT)
- 2026-11-10 (within 30 days) 10-Q filed (FORM 10-Q QUARTERLY REPORT FOR 09-30-2026)
- 2026-11-10 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-14 (older) 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-08-05 (older) 10-Q filed (FORM 10-Q QUARTERLY REPORT FOR 06-30-2026)
- 2026-08-05 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-06-30 (older) 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:KRMD The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
4 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 704440 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | KRMD / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 133044880 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000704440 | SEC EDGAR / IRS |
| CUSIP | 759910102 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000704440 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $41,127,366 | 2025-12-31 | 10-K, XBRL Revenues | as filed | 2026-11-22 09:19 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$2,637,926 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-22 09:19 UTC | Report an error |
| Total assets (at 2025-12-31) | $28,200,179 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-22 09:19 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $17,047,922 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-22 09:19 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $8,872,212 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-22 09:19 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 09:19 UTC | Report an error |
| SIC industry | 3841 Surgical & Medical Instruments & Apparatus | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 09:19 UTC | Report an error |
| State of incorporation | DE | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 09:19 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 09:19 UTC | Report an error |
| Business address | 100 CORPORATE DRIVE, MAHWAH, NJ, 07430 | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 09:19 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 09:19 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | $462,405 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-22 09:19 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $932,517 | 2025-12-31 | 10-K, XBRL PaymentsToAcquireProductiveAssets | as filed | 2026-11-22 09:19 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $3,292,672 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-22 09:19 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-10 · accession 0001161697-26-000244
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $11,566,555 | 3 months ended 2026-09-30 | 10-Q | 2026-11-10 | 0001161697-26-000244 | 2026-11-22 09:19 UTC | Report an error |
| Net income (loss) | $218,103 | 3 months ended 2026-09-30 | 10-Q | 2026-11-10 | 0001161697-26-000244 | 2026-11-22 09:19 UTC | Report an error |
| Cash and cash equivalents | $7,364,200 | at 2026-09-30 | 10-Q | 2026-11-10 | 0001161697-26-000244 | 2026-11-22 09:19 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-16 Filing S-3 filed (FORM S-3 REGISTRATION STATEMENT)
- 2026-11-12 Filing S-8 filed (FORM S-8 REGISTRATION STATEMENT)
- 2026-11-10 Filing 10-Q filed (FORM 10-Q QUARTERLY REPORT FOR 09-30-2026)
- 2026-11-10 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-14 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-08-05 Filing 10-Q filed (FORM 10-Q QUARTERLY REPORT FOR 06-30-2026)
- 2026-08-05 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-06-30 Filing 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2026-05-21 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-05-06 Filing 10-Q filed (FORM 10-Q QUARTERLY REPORT FOR 03-31-2026)
- 2026-05-06 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-09 Filing DEF 14A filed (SCHEDULE 14A DEFINITIVE PROXY STATEMENT)
- 2026-04-03 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 9.01 exhibits
- 2026-03-16 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-03-12 Filing 10-K filed (FORM 10-K ANNUAL REPORT FOR 12-31-2025)
- 2026-03-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-02-11 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-01-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-01-05 Filing S-8 filed (FORM S-8 REGISTRATION STATEMENT)
- 2025-11-25 Filing 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2025-11-12 Filing 10-Q filed (FORM 10-Q QUARTERLY REPORT FOR 09-30-2025)
- 2025-11-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-08-13 Filing S-8 filed (FORM S-8 REGISTRATION STATEMENT)
- 2025-08-06 Filing 10-Q filed (FORM 10-Q QUARTERLY REPORT FOR 06-30-2025)
- 2025-08-06 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
8-K item text, as filed (excerpts)
- 2026-11-10 8-K Item 2.02, RESULTS OF OPERATIONS AND FINANCIAL CONDITION
(a) Public Announcement or Release. On November 10, 2026, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the third fiscal quarter ended September 30, 2026 and updating financial guidance for the fiscal year ended December 31, 2026. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. A related conference call will be held on November 10, 2026 at 4:30pm Eastern Time. KORU Medical is making reference to non-GAAP financial measures in both the press release and the conference call. Our management believes that investors’ understanding of KORU Medical’s performance is enhanced by disclosing the… the 8-K · retrieved 2026-11-22 09:19 UTC - 2026-08-14 8-K Item 5.03, AMENDMENT TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR
Effective August 13, 2026, the Board of Directors (the “Board”) of KORU Medical Systems, Inc. (the “Company”) unanimously adopted a resolution to amend Section 3.05 of the Company’s Amended and Restated By-laws (“By-laws”) to state that, in compliance with the Delaware General Corporation Law, the authority to remove a director from the Board is vested exclusively in the affirmative vote of shareholders holding a majority of the Company’s outstanding shares. The Board has not previously voted to remove, and has not had any intention or agreement to vote to remove, any director from the Board. A copy of the amendment to the By-laws is attached as Exhibit 3.1 hereto and incorporated by… the 8-K · retrieved 2026-11-22 09:19 UTC - 2026-08-05 8-K Item 2.02, RESULTS OF OPERATIONS AND FINANCIAL CONDITION
(a) Public Announcement or Release. On August 5, 2026, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the second fiscal quarter ended June 30, 2026 and updating financial guidance for the fiscal year ended December 31, 2025. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. A related conference call will be held on August 5, 2026 at 4:30pm Eastern Time. KORU Medical is making reference to non-GAAP financial measures in both the press release and the conference call. Our management believes that investors’ understanding of KORU Medical’s performance is enhanced by disclosing the non-GAAP… the 8-K · retrieved 2026-11-22 09:19 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | First Light Asset Management, LLC | $14,229,188 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:19 UTC | Report an error |
| 2 | Topline Capital Management, LLC | $14,170,136 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:19 UTC | Report an error |
| 3 | BlackRock, Inc. | $11,039,079 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:19 UTC | Report an error |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $7,636,108 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:19 UTC | Report an error |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | $4,739,228 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:19 UTC | Report an error |
| 6 | Simcoe Capital LLC | $3,475,051 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:19 UTC | Report an error |
| 7 | Meros Investment Management, LP | $3,190,589 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:19 UTC | Report an error |
| 8 | Lionhunter Capital Management, LLC | $2,911,184 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:19 UTC | Report an error |
| 9 | STATE STREET CORP | $2,715,602 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:19 UTC | Report an error |
| 10 | Archon Capital Management LLC | $2,700,277 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:19 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
4 state and city records carry this company's exact name, from 2 sources. Possible matches only.
ClinicalTrials.gov (2)
possible match: matched by name only, not merged (2)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchKORU Medical Systems · exact name match to 'KORU Medical Systems, Inc.' (no other entity shares the name) · sx:ctgov:h50867ec0208ba3d0 Compare
- possible matchKORU Medical Systems, Inc. · exact legal name · sx:ctgov:h1b70d080da3eeed5 Compare
State licences (2)
possible match: matched by name only, not merged (2)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchKORU MEDICAL SYSTEMS · exact name match to 'KORU Medical Systems, Inc.' (no other entity shares the name) · sx:elic:ctcred:2482861 Compare
- possible matchKORU MEDICAL SYSTEMS · exact name match to 'KORU Medical Systems, Inc.' (no other entity shares the name) · sx:elic:ctcred:2477515 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/704440.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0000704440. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.